###begin article-title 0
Topological Analysis of MAPK Cascade for Kinetic ErbB Signaling
###end article-title 0
###begin p 1
Conceived and designed the experiments: MH SY MS. Performed the experiments: NY MS. Analyzed the data: TN TN. Contributed reagents/materials/analysis tools: SY MS. Wrote the paper: TN.
###end p 1
###begin p 2
###xml 519 534 <span type="species:ncbi:10029">Chinese hamster</span>
Ligand-induced homo- and hetero-dimer formation of ErbB receptors results in different biological outcomes irrespective of recruitment and activation of similar effector proteins. Earlier experimental research indicated that cells expressing both EGFR (epidermal growth factor receptor) and the ErbB4 receptor (E1/4 cells) induced E1/4 cell-specific B-Raf activation and higher extracellular signal-regulated kinase (ERK) activation, followed by cellular transformation, than cells solely expressing EGFR (E1 cells) in Chinese hamster ovary (CHO) cells. Since our experimental data revealed the presence of positive feedback by ERK on upstream pathways, it was estimated that the cross-talk/feedback pathway structure of the Raf-MEK-ERK cascade might affect ERK activation dynamics in our cell system. To uncover the regulatory mechanism concerning the ERK dynamics, we used topological models and performed parameter estimation for all candidate structures that possessed ERK-mediated positive feedback regulation of Raf. The structure that reliably reproduced a series of experimental data regarding signal amplitude and duration of the signaling molecules was selected as a solution. We found that the pathway structure is characterized by ERK-mediated positive feedback regulation of B-Raf and B-Raf-mediated negative regulation of Raf-1. Steady-state analysis of the estimated structure indicated that the amplitude of Ras activity might critically affect ERK activity through ERK-B-Raf positive feedback coordination with sustained B-Raf activation in E1/4 cells. However, Rap1 that positively regulates B-Raf activity might be less effective concerning ERK and B-Raf activity. Furthermore, we investigated how such Ras activity in E1/4 cells can be regulated by EGFR/ErbB4 heterodimer-mediated signaling. From a sensitivity analysis of the detailed upstream model for Ras activation, we concluded that Ras activation dynamics is dominated by heterodimer-mediated signaling coordination with a large initial speed of dimerization when the concentration of the ErbB4 receptor is considerably high. Such characteristics of the signaling cause the preferential binding of the Grb2-SOS complex to heterodimer-mediated signaling molecules.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 122 125 122 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Olayioye1">[1]</xref>
###xml 127 130 127 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Yarden1">[2]</xref>
###xml 226 229 226 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Wiseman1">[3]</xref>
###xml 231 234 231 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Xia1">[4]</xref>
###xml 395 398 395 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-GrausPorta1">[5]</xref>
###xml 399 402 399 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Schulze1">[7]</xref>
###xml 745 748 745 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Alroy1">[8]</xref>
###xml 749 753 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Cohen1">[10]</xref>
###xml 1210 1213 1202 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Alroy1">[8]</xref>
###xml 1215 1219 1207 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Cohen1">[10]</xref>
###xml 1660 1664 1652 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Nagashima1">[11]</xref>
###xml 1913 1917 1905 1909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Kao1">[12]</xref>
###xml 1918 1922 1910 1914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Moelling1">[14]</xref>
###xml 109 114 <span type="species:ncbi:9606">human</span>
Overexpression or mutation of the ErbB receptor is closely correlated with the incidence of various kinds of human cancer [1], [2]. The risk of cancer becomes especially elevated when different ErbB receptors are co-expressed [3], [4]. This phenomenon is also confirmed at the cellular level, where transformation of cells occurs when different ErbB receptors are co-expressed in the same cells [5]-[7]. However, this cellular transformation mechanism has not been identified because an investigation of the primary interaction of adaptor proteins following kinase activation induced by growth hormones results in relatively small differences in protein binding patterns for cells expressing either single- or multiple-species of ErbB receptors [8]-[10]. For example, EGF (epidermal growth factor)-stimulated EGFR (epidermal growth factor receptor) in ErbB4 co-expressing cells essentially interacts with adaptor and effector proteins such as growth factor receptor-bound protein2 (Grb2), Src homology and collagen domain protein (Shc), the p85 subunit of phosphatidylinositol 3'-kinase (PI3K), Cbl and phospholipase Cgamma (PLCgamma) in a manner that is similar to EGF-stimulated cells solely expressing EGFR [8], [10]. Therefore, the increase in biological response elicited by the coexpression of ErbB receptors cannot be solely explained by specific protein interactions induced by each receptor. Recently, it was understood that quantitative (strength and duration of activities of the pathways) rather than qualitative (e.g. regulation of different pathways) differences between signaling pathways may largely account for dissimilar biological responses [11]. This explanation may be relevant to a general investigation of factors determining ligand-specific or receptor-specific signal transduction pathways when considering the fact that mammalian cells share almost the same sets of signaling components [12]-[14].
###end p 4
###begin p 5
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Moelling1">[14]</xref>
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Reusch1">[15]</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Chen1">[16]</xref>
###xml 230 234 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Holt1">[17]</xref>
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Balan1">[18]</xref>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Dougherty1">[20]</xref>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Hatakeyama1">[21]</xref>
###xml 301 316 <span type="species:ncbi:10029">Chinese hamster</span>
Several studies indicated that signal amplitude and duration are temporally modulated by cross-talk between two pathways (e.g. Raf inhibition by Akt) [14], [15] and inhibitory feedback from ERK to Grb2-SOS complex formation [16], [17] and Raf [18]-[20]. Furthermore, our previous study indicated that Chinese hamster ovary (CHO) cells expressing both EGFR and ErbB4 receptors (E1/4 cells) induced specific B-Raf and higher ERK activation than cells solely expressing the EGFR receptor (E1 cells) and induced cellular transformation [21]. It is therefore understood that regardless of the same primary recruitment of effector proteins to each ErbB receptor dimer, the cells induce different structures of downstream regulatory pathways and that such differences might cause a change in the kinase activity level in relation to the cell fate determination process.
###end p 5
###begin p 6
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Balan1">[18]</xref>
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Dougherty1">[20]</xref>
###xml 544 548 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Garnett1">[22]</xref>
###xml 550 554 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Rushworth1">[23]</xref>
###xml 977 981 977 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Heinrich1">[24]</xref>
###xml 999 1003 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Huang1">[25]</xref>
###xml 1826 1830 1826 1830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Kholodenko1">[26]</xref>
###xml 650 664 <span type="species:ncbi:10029">CHO cell lines</span>
The aim of the present study is to give a mechanistic insight into how E1/4 cells induce a higher amplitude of ERK activity than E1 cells and how B-Raf is involved in ERK activation in an E1/4 cell-specific manner. Our experimental data showed that the inhibiting kinase activity of MEK (MAP kinase kinase) on ERK lowered the MEK response with EGF, indicating that there might exist positive feedback by ERK somewhere within upstream pathways. Furthermore, there are increasing reports of cross-talk between Raf-1 and B-Raf pathways [18]-[20], [22], [23]. However, the pathway structure of feedback/cross-talk in the MAPK cascade is not clear in our CHO cell lines. Therefore, we estimated the structure based on model parameter estimation examining which structures could reliably reproduce the experimental data with respect to the signal amplitude and duration of the signaling molecules. Although a main structure of MAPK cascade was originally analyzed by Heinrich et al. [24] and Huang et al. [25], we are the first to apply the topological modeling to CHO cells by adding cross-talk and feedback to explain ERK activation dynamics. As a result, we specified a structure that possesses both negative cross-talk regulation by B-Raf to Raf-1 and positive feedback by ERK to B-Raf. The steady-state analysis of the estimated pathway structure of the Raf-MEK-ERK cascade indicated that the amplitude of Ras activity might critically affect ERK activity through ERK-B-Raf positive feedback coordination with sustained B-Raf activation in E1/4 cells. On the other hand, it was shown that the amplitude of Rap1 activity might be less influential on ERK activity. Accordingly, we further investigated differences in amplitude of Ras activity in ErbB signaling pathways using a detailed upstream model modified from Kholodenko's [26]. The sensitivity analysis indicated that the initial reaction velocity of EGFR/ErbB4 receptor heterodimerization might be considerably higher than that of EGFR homodimerization, and as a result, the Grb2-SOS complex preferentially binds to the activated heterodimer rather than the activated homodimer. Finally, we concluded that the amplitude of Ras activity becomes more potent under high expression of the ErbB4 receptor in E1/4 cells.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
Estimation of the feedback and cross-talk structure of the Raf-MEK-ERK cascade in CHO cells using a mathematical model
###end title 8
###begin p 9
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Favata1">[27]</xref>
###xml 739 747 739 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g001">Figure 1</xref>
###xml 832 841 832 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s011">Figure S1</xref>
###xml 1080 1084 1080 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Dougherty1">[20]</xref>
###xml 1086 1090 1086 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Garnett1">[22]</xref>
###xml 1092 1096 1092 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Rushworth1">[23]</xref>
###xml 1243 1251 1243 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g002">Figure 2</xref>
###xml 1360 1364 1360 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Heinrich1">[24]</xref>
###xml 1508 1512 1508 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Markevich1">[28]</xref>
###xml 1513 1517 1513 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Brightman1">[30]</xref>
###xml 1590 1611 1590 1611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 2045 2049 2045 2049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Chen1">[16]</xref>
We first experimentally investigated the presence of feedback regulation by ERK on upstream signal transduction pathways using the MEK inhibitor. The MEK-mediated activation of ERK through phosphorylation of ERK threonine/tyrosine residues has been well established. The inhibition of kinase activity of MEK on ERK and subsequent measurement of MEK phosphorylation represents one approach that could be used to evaluate the effect of ERK-mediated feedback on the upstream pathways. U0126 is a selective inhibitor of MEK and can therefore be used to block the phosphorylation of ERK by MEK [27]. Results indicated that EGF-induced MEK activity decreased when ERK activation was inhibited through the use of U0126 in both E1 and E1/4 cells (Figure 1) (The Western blot data relating to ERK activity following U0126 use is provided in Figure S1). This fact implied positive feedback regulation by ERK on upstream molecules, although the feedback point was not clear. Additionally, there is a possibility of cross-talk between Raf isoforms, which has been reported in many cell lines [20], [22], [23]. In order to determine the structure of feedback/cross-talk in CHO cells, we carried out topological modeling of the central Raf-MEK-ERK cascade (Figure 2). We began by using the main structure of the MAPK cascade (steps 1-11) originally given by Heinrich et al. [24], and then included feedback (steps 13, 15, 16, 18), cross-talk (steps 12, 14, 17, 19), and dual phosphorylation of ERK (steps 8-11) components [28]-[30]. Detailed information pertaining to model construction is summarized in Materials and Methods. We assumed that the structure and kinetic parameters are identical for E1 and E1/4 cells, whereas time courses relating to Ras- and Rap1-GTPs, which represent inputs of the cascade, can differ. Moreover, we assumed that the effect of feedback regulation by ERK on upstream pathways can be approximated by the effect on Raf activity. For instance, suppose that SOS (Son of Sevenless homologue protein) is negatively regulated by ERK [16], and the down-regulation of SOS activity reduces Raf-1 activity via the down-regulation of Ras. Raf-1 activation is then modeled with ERK negative feedback in our topological model. Similarly, we assumed cross-talk regulation between Raf-1 and B-Raf.
###end p 9
###begin title 10
The effect of MEK inhibitor U0126 on MEK phosphorylation in E1 and E1/4 cells.
###end title 10
###begin p 11
###xml 487 495 487 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s002">Table S1</xref>
Serum-starved E1 and E1/4 cells were incubated with 10 nM EGF for the indicated time period with or without pretreatment of 200 nM U0126. MEK phosphorylation was analyzed by Western blot with the corresponding anti-phospho-specific MEK antibodies (upper panel), and then reblotted with an anti-MEK antibody (lower panel). (A) Western blot for E1 cells. (B) Western blot for E1/4 cells. Data show a representative figure of three independent experiments. Quantified data are available in Table S1 (no. 3).
###end p 11
###begin title 12
Topological model of the Raf-MEK-ERK cascade in CHO cells.
###end title 12
###begin p 13
###xml 392 400 392 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s006">Table S5</xref>
The inputs of the Raf-MEK-ERK cascade are the activated forms of Ras and Rap1, Ras-GTP and Rap1-GTP. The output is the doubly phosphorylated ERK, ERKPP. Steps 1-11 are the fixed part of the cascade, whereas steps 12-19 are possible cross-talk/feedback connections to be determined. The selected pathways were steps 14 and 16 (red arrows). Numbers shown correspond to the kinetic equations in Table S5.
###end p 13
###begin p 14
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 552 560 552 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g001">Figure 1</xref>
###xml 916 924 916 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g003">Figure 3</xref>
Steps 12-19 were included as possible candidates of feedback/cross-talk connections that should be determined. The number of possible structures regarding cross-talk and feedback is 81 ( = 34) since there can be three kinds of regulation (positive, negative, or not present) for each of four interactions, ERK to Raf-1 (steps 13 and 15), ERK to B-Raf (steps 16 and 18), Raf-1 to B-Raf (steps 17 and 19), and B-Raf to Raf-1 (steps 12 and 14). In order to narrow the candidates, we took into account the experimentally observed positive feedback by ERK (Figure 1). Moreover, for simplicity we excluded the situation involving the coexistence of both Raf-1 regulation by B-Raf and B-Raf regulation by Raf-1. These constraints narrowed down the 81 possible candidates to 29 structures that contain direct/indirect positive feedback by ERK to B-Raf (nos. 1-10), Raf-1 (nos. 11-20), and both B-Raf and Raf-1 (nos. 21-29) (Figure 3).
###end p 14
###begin title 15
The 29 pathway structures that possess positive feedback by ERK to Raf.
###end title 15
###begin p 16
The 29 pathway structures that possess positive feedback by ERK to Raf isoforms can be classified into three types of regulation depending on which isoform is positively regulated: B-Raf (nos. 1-10), Raf-1 (nos. 11-20), or both B-Raf and Raf-1 (nos. 21-29). The symbol for MEK is omitted here for clarity.
###end p 16
###begin p 17
###xml 604 621 604 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001782-t001">Table 1, nos. 1&#8211;3</xref>
###xml 744 752 744 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g004">Figure 4</xref>
###xml 757 778 757 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001782-t001">Table 1, nos. 4 and 5</xref>
###xml 856 863 856 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s001">Text S1</xref>
###xml 865 874 865 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s003">Tables S2</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s004">S3</xref>
###xml 880 882 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s005">S4</xref>
###xml 887 897 887 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s012">Figures S2</xref>
###xml 902 904 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s013">S3</xref>
###xml 980 994 980 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001782-t001">Table 1, no. 6</xref>
###xml 1139 1160 1139 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
For each of the 29 structures, we estimated the model parameters to reproduce the experimental data. Here, we employed the hypothesis that appropriate structures could explain experimental results using suitable kinetic parameters. Additionally, we also hypothesized that a biological pathway is robust against small parameter changes, and that the parameter should therefore be easily searched when the pathway structure is solid. For parameter estimation, we prepared 29 ODE (ordinary differential equation) models and six time-course datasets each from the Western blot analyses of E1 and E1/4 cells (Table 1, nos. 1-3). Additionally, we developed an input signal generator to reproduce the experimental data relating to Ras- and Rap1-GTPs (Figure 4 and Table 1, nos. 4 and 5). Detailed information relating to the input signal generator is provided in Text S1, Tables S2, S3, S4 and Figures S2 and S3. Moreover, we experimentally measured the time course of B-Raf activation (Table 1, no. 6), which showed sustained activation, for validation of the model. The procedure of model selection based on parameter estimation is provided in Materials and Methods.
###end p 17
###begin title 18
Time courses of Ras- and Rap1-GTPs.
###end title 18
###begin p 19
The input signal generator reproduced the time-course data of Ras- and Rap1-GTPs with 10 nM EGF. (A) Normalized time-course data of Ras-GTP. (B) Normalized time-course data of Rap1-GTP. The graphs represent the normalized activity of Ras- and Rap-1 GTPs in which the data are divided by the value for E1/4 cells at 1 min. Blue and red lines correspond to simulation data for E1 and E1/4 cells, respectively. The filled squares and circles correspond to experimental data concerning E1 and E1/4 cells, respectively.
###end p 19
###begin title 20
Time-course data from Western blot analysis.
###end title 20
###begin p 21
###xml 43 64 43 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 99 107 99 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s002">Table S1</xref>
The experimental protocol is summarized in Materials and Methods. The quantified data are shown in Table S1. All experiments were performed using 10 nM EGF.
###end p 21
###begin p 22
###xml 222 231 222 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g005">Figure 5A</xref>
###xml 263 272 263 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s014">Figure S4</xref>
###xml 1185 1194 1185 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s006">Tables S5</xref>
###xml 1199 1201 1199 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s007">S6</xref>
Application of the aforementioned selection process yielded two structures (numbers 4 and 29) that satisfied all criteria for model selection. In fact, the simulation results were quite similar for the two structures (see Figure 5A for the number 4 structure and Figure S4 for all structures). Interestingly, both structures possess positive feedback by ERK to B-Raf and negative cross-talk regulation by B-Raf to Raf-1, and the difference between the two structures being the absence or presence of ERK-mediated positive feedback regulation of Raf-1. However, we found that the ERK-mediated regulation of Raf-1 in number 29 structure was negligible since the maximum velocity was markedly smaller than that determined for Ras-GTP, indicating that the number 29 structure was essentially the same as the number 4 structure. Therefore, we concluded that the structure of the Raf-MEK-ERK cascade in E1 and E1/4 cells might be characterized by the number 4 structure, which possesses negative cross-talk regulation by B-Raf to Raf-1 and positive feedback by ERK to B-Raf (steps 14 and 16). The model description and kinetic parameters pertaining to the number 4 structure are provided in Tables S5 and S6.
###end p 22
###begin title 23
The time-course simulation and steady-state responses of the number 4 structure.
###end title 23
###begin p 24
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 312 313 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
(A) The simulation results are shown with the corresponding experimental data. Filled squares and circles indicate experimental data relating to E1 and E1/4 cells, respectively. Blue and red lines indicate the simulation data relating to E1 and E1/4 cells, respectively. The x-axis represents time (min) and the y-axis activation (% of total protein). In (B) and (C) the steady-state responses of ERK and B-Raf activity for the selected pathway structure are shown. The input signal levels of Ras- and Rap1-GTPs to the Raf-MEK-ERK cascade characterized by the number 4 structure were changed in the range 0.1 to 2.0. The simulation for each input level was then ran for 100,000 sec to approximate the steady-state values where the activity of all molecules hardly moved at about the termination time of the simulation. (B) 3-D graph of steady-state ERK activity. (C) 3-D graph of steady-state B-Raf activity. The colors of the graphs indicate activation (% of total protein). Open and filled circles correspond to the activation level induced by the input level equivalent to the peak level of Ras-GTP in E1 and E1/4 cells, respectively. Similarly, open and filled squares correspond to the activation level induced by the input level equivalent to the activity level 30 min following EGF stimulation of Ras-GTP in E1 and E1/4 cells, respectively.
###end p 24
###begin title 25
Characteristics of the estimated pathway structure of the Raf-MEK-ERK cascade
###end title 25
###begin p 26
###xml 202 219 202 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g005">Figures 5B and 5C</xref>
###xml 465 474 465 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g005">Figure 5B</xref>
###xml 677 686 677 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g005">Figure 5C</xref>
###xml 1065 1080 1061 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001782-t001">Tables 1, no. 7</xref>
###xml 1082 1086 1078 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Hatakeyama1">[21]</xref>
In order to investigate the characteristics of the identified pathway structure, we next carried out a steady-state analysis for ERK and B-Raf responses under the constant inputs of Ras- and Rap1-GTPs (Figures 5B and 5C). As a result, we found that ERK activity increased with a steep slope along with the input level of Ras-GTP coordination with ERK-B-Raf positive feedback that can stabilize the promotion of ERK activity, but be insensitive to that of Rap1-GTP (Figure 5B). This indicated that ERK activity might be regulated predominantly by Ras activity rather than Rap1 activity in this pathway structure. Interestingly, this conclusion was also true for B-Raf activity (Figure 5C), although B-Raf can also be regulated by Rap1-GTP. If this is the case, Rap1 activity would be less influential on ERK activity. In order to confirm the lesser impact of Rap1 activity on ERK activity, we compared ERK activity 5 min after 10 nM EGF treatment in the presence or absence of the PLCgamma inhibitor U73122, which can indirectly suppress Rap1 activity in CHO cells (Tables 1, no. 7) [21]. U73122 showed less effect on ERK activity both in E1 and E1/4 cells, and is consistent with the above-mentioned perspective based on steady-state analysis.
###end p 26
###begin p 27
###xml 12 21 12 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g004">Figure 4A</xref>
###xml 262 279 262 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g005">Figures 5B and 5C</xref>
###xml 691 700 691 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g005">Figure 5B</xref>
###xml 1027 1036 1027 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g005">Figure 5C</xref>
###xml 1285 1294 1285 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g004">Figure 4A</xref>
###xml 1380 1389 1380 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g005">Figure 5C</xref>
###xml 1471 1480 1471 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g005">Figure 5B</xref>
As shown in Figure 4A, the peak level of Ras activation in E1/4 cells was considerably higher than that of E1 cells. We marked the points at which the amplitude of ERK and B-Raf activity would be induced by input levels equivalent to the peak values of Ras-GTP (Figures 5B and 5C) to determine the extent to which the differences impact on ERK and B-Raf activity. Since the input level of Rap1-GTP was not sensitive to ERK activity, we placed symbols at a zero input level of Rap1-GTP for clarity. Notably, the peak activity of Ras-GTP in E1/4 cells was placed at the upper level of ERK activity over the steep slope in comparison with that of E1 cells, which was placed at the lower level (Figure 5B). Therefore, we concluded that the experimentally observed difference in amplitude of ERK activity was mainly caused by differences in amplitude of Ras activity between E1 and E1/4 cells. Unlike the case of ERK, the peak activity of Ras-GTP in E1 cells was placed at the upper part of the slope of the B-Raf activity profile (Figure 5C); the amplitude of B-Raf activity is therefore quite close to that for E1/4 cells. Furthermore, we investigated ERK and B-Raf activities that would be induced by input levels equivalent to Ras activity 30 min following EGF treatment as depicted in Figure 4A. We found that B-Raf activity at 30 min differed markedly between E1 and E1/4 cells (Figure 5C), whereas ERK activity returned to considerably lower levels in both cell lines (Figure 5B). This implies that B-Raf activity would be sustained for a greater period of time in E1/4 cells than in E1 cells. Taken together, these results indicate that the characteristics of the Raf-MEK-ERK cascade are determined mainly by the amplitude of Ras activity and not Rap1 activity. Additionally, differences in the peak level of ERK activity between E1 and E1/4 cells might result from differences in Ras activation amplitude coordination with E1/4 cell-specific sustained B-Raf activation.
###end p 27
###begin title 28
Detailed upstream model of EGFR/ErbB4 heterodimer-mediated Ras activation
###end title 28
###begin p 29
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Kolch1">[31]</xref>
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Brightman1">[30]</xref>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Maruta1">[32]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Yumoto1">[33]</xref>
###xml 931 939 931 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g006">Figure 6</xref>
###xml 1111 1119 1111 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g006">Figure 6</xref>
###xml 1224 1232 1224 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g006">Figure 6</xref>
###xml 1691 1695 1691 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Kholodenko1">[26]</xref>
###xml 1781 1785 1781 1785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Hatakeyama2">[29]</xref>
###xml 1942 1951 1942 1951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g007">Figure 7A</xref>
###xml 2031 2040 2031 2040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g007">Figure 7C</xref>
###xml 2358 2379 2358 2379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001782-t001">Table 1, nos. 4, 8&#8211;10</xref>
###xml 2408 2429 2408 2429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 2540 2549 2540 2549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s008">Tables S7</xref>
###xml 2554 2556 2554 2556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s009">S8</xref>
###xml 2908 2916 2908 2916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g007">Figure 7</xref>
Many studies revealed that ErbB receptor-mediated Ras signaling is deeply involved in ERK activation upon EGF stimulation [31]. Interestingly, it was reported that Shc activity, which results in Ras activation [30], [32], might be regulated by mechanisms that differ between E1 and E1/4 cells [33]. However, the detailed mechanism concerning EGFR/ErbB4 heterodimer-mediated signaling is still unclear. In the previous section we demonstrated that differences in amplitude of ERK activity between the two cell lines might be caused predominantly by different Ras activities independently of Rap1 activation dynamics, where we assumed that the pathway structure and kinetic parameters of the central Raf-MEK-ERK cascade were the same. We therefore constructed a detailed upstream model of EGFR/ErbB4 heterodimer-mediated Ras activation to predict how differences in amplitude of Ras activity between E1 and E1/4 cells can be caused (Figure 6). We assumed that one of the crucial factors is the presence of the ErbB4 receptor in the pathways, implying that homodimer-mediated pathways (steps 1-12, the left box in Figure 6) are common in the two cell lines and that heterodimer-mediated pathways (steps 14-22, the right box in Figure 6) are E1/4 cell-specific. For a simulation of E1 cells, the concentration of the ErbB4 receptor was set to zero. Then, steps 14-22 were inactive and Ras activity could be controlled by only E11P_ShcP_GS (step 12), otherwise control was achieved through E11P_ShcP_GS and E14P_ShcP_GS (steps 12 and 22). Steps 1-11, which include Shc recruitment to the receptor, binding to the Grb2-SOS complex and receptor internalization, were adopted from the earlier study [26]. However, those were re-simplified to maintain the essential dynamics of the pathway [29]. Our experimental data indicated that the signal amplitude of EGFR phosphorylation was similar in E1 and E1/4 cells although the dynamics seemed to differ (Figure 7A), while the amplitude and dynamics of Shc phosphorylation were very different (Figure 7C). Therefore, we hypothetically introduced the steps 14-22 in order to take into account the effect of ErbB4 receptor-mediated signaling on Shc and Ras regulation. Kinetic parameters were also estimated using GLSDC (Genetic Local Search with distance independent Diversity Control) by comparing the experimental data (Table 1, nos. 4, 8-10) with simulated values (See Materials and Methods for parameter estimation of the upstream model). The model description and kinetic parameters are provided in Tables S7 and S8. When the simulation model was used to examine the effect of a 10 nM EGF perturbation on E1 and E1/4 cells, the model reasonably reproduced a similar signal amplitude of EGFR phosphorylation, different amplitude and dynamics of Shc phosphorylation, different amplitude of Ras activation, and transient dynamics of ErbB4 phosphorylation in E1/4 cells (Figure 7).
###end p 29
###begin title 30
Detailed upstream model of EGFR/ErbB4 heterodimer-mediated Ras activation.
###end title 30
###begin p 31
###xml 563 571 563 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s008">Table S7</xref>
The pathways in the left and right boxes are mediated by the EGFR homodimer and the EGFR/ErbB4 heterodimer, respectively. Ras activation is regulated by these two pathways via steps 12 and 22. When performing parameter estimation of total concentrations and kinetic parameters for the E1/4 cells, all parameters were estimated. On the other hand, the concentration of the ErbB4 receptors was set to zero for E1 cells, while other unknown parameters were considered to be identical as those for the E1/4 cells. Numbers shown correspond to the kinetic equations in Table S7.
###end p 31
###begin title 32
Time-course activity of signaling molecules with 10 nM EGF in ErbB signaling.
###end title 32
###begin p 33
###xml 118 143 118 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001782-t001">Table 1 (nos. 4 and 8&#8211;10)</xref>
The responses of the signaling molecules during 30 min are plotted with the corresponding experimental data listed in Table 1 (nos. 4 and 8-10). (A) Phosphorylated EGFR in E1 and E1/4 cells, respectively. (B) Phosphorylated ErbB4 receptor in E1/4 cells. (C) Phosphorylated Shc in E1 and E1/4 cells, respectively. (D) Ras-GTP in E1 and E1/4 cells, respectively. Blue and red lines indicate simulation data for E1 and E1/4 cells, respectively, and filled squares and circles indicate experimental data E1 and E1/4 cells, respectively. Graphs represent activity (% of total protein).
###end p 33
###begin p 34
###xml 223 232 223 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g008">Figures 8</xref>
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g009">9</xref>
###xml 471 479 471 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g008">Figure 8</xref>
###xml 790 798 790 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g006">Figure 6</xref>
###xml 835 843 835 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g009">Figure 9</xref>
###xml 1049 1066 1049 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g009">Figures 9B and 9D</xref>
###xml 1123 1133 1123 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g009">Figures 9A</xref>
###xml 1273 1282 1273 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g009">Figure 9C</xref>
###xml 1318 1327 1318 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g009">Figure 9D</xref>
###xml 1560 1577 1560 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g009">Figures 9A and 9B</xref>
Next, we investigated the effect of ErbB4 receptor-mediated pathways on Ras activation. To this end, we varied the concentration of the ErbB4 receptor from about 100% of the total ErbB4 receptors in E1/4 cells to about 0% (Figures 8 and 9). The model with 0% ErbB4 receptors corresponds to the E1 cell model. As the abundance of ErbB4 receptors increased, the peak level of activation of E14P_ShcP_GS increased with a steep slope, whereas that of E11P_ShcP_GS decreased (Figure 8). Furthermore, we found that the peak level of E14P_ShcP_GS was much greater than that of E11P_ShcP_GS, especially for higher concentrations of the ErbB4 receptor. Therefore, the peak level of Ras activation might be critically affected by the concentration of ErbB4 receptors through E14P_ShcP_GS (step 22 in Figure 6) rather than E11P_ShcP_GS (step12). Figure 9 shows the time-course patterns of signaling molecules in this sensitivity analysis. The change in peak level of E14P_ShcP was also affected by the concentration of ErbB4 receptors as well as E14P_ShcP_GS (Figures 9B and 9D), although E11P_ShcP was not sensitive to such changes (Figures 9A). However, the peak level of E11P_ShcP_GS became quite small at around a 100% concentration of ErbB4 receptors despite such insensitivity (Figure 9C) compared to that of E14P_ShcP_GS (Figure 9D). E11P_ShcP and E14P_ShcP share the interaction partner, the GS (Grb2-SOS) complex. In addition, the initial reaction velocity of E14P_ShcP was faster than that of E11P_ShcP at higher concentrations of the ErbB4 receptor (60-100%) (Figures 9A and 9B). Therefore, GS might preferentially bind to E14P_ShcP rather than E11P_ShcP. These results as a whole indicate that the concentration of the ErbB4 receptor in our detailed model might be quite important for the considerably strong Ras activation observed in E1/4 cells, where the ErbB4 receptor-mediated signaling pathway can dominate Ras activation dynamics.
###end p 34
###begin title 35
Effect of ErbB4 receptor concentration on E11P_ShcP_GS and E14P_ShcP_GS.
###end title 35
###begin p 36
###xml 51 59 51 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g006">Figure 6</xref>
The two complexes E11P_ShcP_GS and E14P_ShcP_GS in Figure 6 regulate Ras activity. The solid and dashed lines represent the change in peak activity (%) of E14P_ShcP_GS and E11P_ShcP_GS, respectively, following 10 nM EGF treatment and depending on the concentration of ErbB4 receptors in the detailed upstream model, respectively. The 0% ErbB4 receptor concentration (E4 = 0) is regarded as representing E1 cells, while the 100% level (E4 = 1.0) represents E1/4 cells.
###end p 36
###begin title 37
Effect of ErbB4 receptor concentration on the time-course pattern.
###end title 37
###begin p 38
The concentration of the ErbB4 receptor (E4) was changed from 100% of the total ErbB4 receptors (E4 = 1.0) in E1/4 cells to 0% (E4 = 0.0). Figures demonstrate time-course patterns of signaling molecules in relation to the abundance of the ErbB4 receptor in silico. (A) and (C) The signaling molecules E11P_ShcP and E11P_ShcP_GS in EGFR homodimer-mediated pathways, respectively. (B) and (D) The signaling molecules E14P_ShcP and E14P_ShcP_GS in EGFR/ErbB4 heterodimer-mediated pathways, respectively. The colors of the graphs indicate activity (% of total protein).
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 153 156 153 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Wiseman1">[3]</xref>
###xml 157 160 157 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Holbro1">[6]</xref>
###xml 567 571 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Hatakeyama1">[21]</xref>
Cells co-expressing different ErbB receptors tend to undergo cellular transformation more frequently than cells expressing a single type of the receptor [3]-[6]. Our earlier study reported that cellular transformation occurs only in cells co-expressing both EGFR and ErbB4 receptors, but not in cells expressing only EGFR or ErbB4, suggesting that different cell fates might originate from the enhancement of ERK activation mediated by E1/4 cell-specific B-Raf activation, although homo- and hetero-dimers could recruit similar effector proteins upon EGF stimulation [21]. Therefore, a question is raised concerning how the signal amplitude of the signal transduction pathway and the cell-specific activation were controlled in the ErbB receptor co-expression system.
###end p 40
###begin p 41
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Roberts1">[34]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Kao1">[12]</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Balan1">[18]</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Garnett1">[22]</xref>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Marais1">[35]</xref>
###xml 505 522 505 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001782-t001">Table 1, nos. 1&#8211;3</xref>
###xml 637 658 637 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001782-t001">Table 1, nos. 4 and 5</xref>
###xml 709 717 709 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g004">Figure 4</xref>
###xml 1170 1173 1170 1173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">753</sup>
###xml 1283 1287 1283 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Rushworth1">[23]</xref>
###xml 1577 1581 1577 1581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Marais1">[35]</xref>
###xml 1682 1686 1682 1686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Kao1">[12]</xref>
###xml 1789 1793 1789 1793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Balan1">[18]</xref>
###xml 1851 1855 1851 1855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Garnett1">[22]</xref>
###xml 2402 2406 2402 2406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Santos1">[36]</xref>
Since the Raf-MEK-ERK cascade is considered a core component of the signaling network, and Raf isoforms are key downstream targets of ErbB receptors [34], it is reasonable to assume that the Raf-MEK-ERK cascade consists of the same structure in E1 and E1/4 cells. However, since the regulation of Raf isoforms is complex and cell-specific [12], [18], [22], [35], we initially estimated the feedback/cross-talk structure of the cascade using topological modeling. In addition to the 6 measured quantities (Table 1, nos. 1-3), the time-course inputs of Ras- and Rap1-GTPs were also utilized as additional constraints in the determination (Table 1, nos. 4 and 5). The time-course patterns of Ras- and Rap1-GTPs (Figure 4) were sufficiently different to allow for a determination of parameters differentiating the Raf-1 and B-Raf pathways. Moreover, given the benefits of simplified modeling using minimal variation of feedback/cross-talk connections, we were able to arrive at a structure that possessed negative cross-talk regulation of Raf-1 by B-Raf and positive feedback by ERK to B-Raf. Since an earlier study indicated that ERK-induced phosphorylation of B-Raf on Thr753 promoted the disassembly of Raf-1/B-Raf heterodimer, followed by low kinase activity of Raf-1 in COS-1 cells [23], this result might support our estimated pathway structure. Activation and deactivation of Raf isoforms are tightly regulated, although the mechanisms involved in this regulation are not fully known. There are reports that B-Raf is activated by Ras and Raf-1 requires additional mediators [35], while 90% of ERK activity is dependent on B-Raf activity in nerve growth factor-induced PC12 cells [12]. On the other hand, contradictory studies showed that Raf-1 is activated by its own feedback from ERK [18] and that Raf-1 activates B-Raf in a Ras-dependent manner [22]. Our simulation analysis only explains topological regulation of time-course events, not the molecular functions. However, the ligand-stimulated Raf activation and deactivation mechanism seemed to involve cell- and ligand type-specific complex events. Therefore, our pathway estimation indicated that one can estimate the hidden regulatory pathways using mathematical modeling. In fact, it was reported that the feedback structure of the MAPK network can be either negative or positive depending on the kind of ligand, EGF or NGF, in PC-12 cells [36].
###end p 41
###begin p 42
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Heinrich1">[24]</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Huang1">[25]</xref>
###xml 869 873 861 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-York1">[37]</xref>
###xml 875 879 867 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Campa1">[38]</xref>
###xml 880 884 872 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Vossler1">[40]</xref>
###xml 973 977 965 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Zwartkruis1">[41]</xref>
###xml 1043 1046 <span type="species:ncbi:10116">Rat</span>
It is well known that ligand-induced activity of signaling proteins in a MAPK cascade can be promoted in an ultrasensitive manner depending on the pathway structure and kinetic parameters [24], [25]. From the steady-state analysis of ERK and B-Raf activity response to the constant input of Ras- and Rap1-GTPs, we found that ERK and B-Raf activity was steeply elevated along with the input level of Ras-GTP in the selected pathway structure, although there was no sensitivity to Rap-1. This lesser effect of Rap1 on ERK activity was also confirmed by Western blot analysis of ERK activation by suppressing the PLCgamma-Rap1 pathway using the specific PLCgamma inhibitor. The role of Rap1 in Ras-mediated signaling is still unclear. Rap1 might be implicated in both negative and positive control of Ras-mediated signaling depending on the kinds of ligand and cell lines [37], [38]-[40]. However, our results might be consistent with the earlier results of Zwartkrius et al. [41] in which it was shown that Rap1 did not affect ERK activation in Rat-1 cells.
###end p 42
###begin p 43
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Hatakeyama1">[21]</xref>
Our earlier study showed that E1/4 cells induced specific B-Raf and higher ERK activation upon EGF stimulation than E1 cells, followed by cellular transformation [21]. From the steady-state analysis, we concluded that the peak level of Ras activity in E1/4 cells was sufficiently high to induce the ultrasensitive ERK activation. On the other hand, activity in E1 cells is near the bottom of the slope of the Ras-ERK steady-state response curve, such that the amplitude of ERK activity in E1 cells became considerably low. In addition, the B-Raf steady-state response induced by the peak level of Ras activity is similar and high in E1 and E1/4 cells, but considerably different when evaluating Ras activity 30 min after EGF stimulation. Such a difference might cause the different B-Raf activation dynamics upon EGF stimulation, which are sustained in E1/4 cells and transient in E1 cells. The sustained B-Raf activation can then stabilize the promotion of ERK activity through the ERK-B-Raf positive feedback loop in E1/4 cells.
###end p 43
###begin p 44
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Kholodenko1">[26]</xref>
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Hatakeyama2">[29]</xref>
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Schoeberl1">[42]</xref>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Shankaran1">[43]</xref>
###xml 962 966 962 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Schoeberl1">[42]</xref>
The mechanism of Ras activation dynamics has been investigated in many studies using mathematical modeling [26], [29], [42]. However, less is known about the effect of heterodimerization on signal transduction pathways. In the present study, we found that the amplitude of Ras activity becomes more potent as the concentration of ErbB4 receptors increases in E1/4 cells. An earlier study revealed that co-expression of EGFR with ErbB2 or ErbB3 biases signaling to the cell surface and retards signal down-regulation, followed by prolonged signaling of downstream molecules [43]. Unlike the ErbB1-3 system, we speculated that the initial reaction velocity of EGFR/ErbB4 receptor heterodimerization might be important and considerably higher than that of EGFR homodimerization in our CHO cells. In fact, the critical parameter in determining signal efficacy for the EGFR homodimer-mediated signal transduction system is the initial velocity of receptor activation [42]. We have reached a similar conclusion with EGFR/ErbB4 heterodimer-mediated signaling, but here we insisted that the initial velocity of heterodimerization might be more effective for Ras activation dynamics than that of the homodimer. If we follow the ODEs of the detailed upstream model, the concentration of dimers, E11 and E14, are modulated by the following ODEs:Since the initial concentrations of E11, E11P, E14 and E14P are equivalent to zero, the initial velocities of E11 and E14 are dominated by the first terms. Therefore, in the rangethe reaction velocity of E14 becomes higher than that of E11, followed by the difference in the initial reaction velocity. Again, it should be noted that such a range would be wider when the concentration of ErbB4 receptors is high.
###end p 44
###begin title 45
Materials and Methods
###end title 45
###begin title 46
Materials
###end title 46
###begin p 47
###xml 921 925 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Hatakeyama1">[21]</xref>
###xml 927 931 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Kim1">[44]</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 795 810 <span type="species:ncbi:10029">Chinese hamster</span>
###xml 852 857 <span type="species:ncbi:9606">human</span>
Recombinant human epidermal growth factor (EGF) was purchased from PeproTech House (London, England). Antibodies for detecting phospho-p44/42 ERK, ERK phospho-MEK and MEK were purchased from Cell Signaling Technology, Inc. (Beverly, MA). Anti-EGFR receptor, anti-ErbB4 receptor, anti-Rap1, anti-Raf and anti-phosphotyrosine (PY20) antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-Ras antibody was purchased from BD Biosciences (San Jose, USA). GST-Ral GDS-Rap binding domain (RDB) agarose, Raf-Ras binding domain (RDB) agarose, anti-Shc, and anti-phospho-Shc (Tyr317) antibodies were purchased from Upstate Biotechnology (Lake Placid, NY). U73122 (PLCgamma inhibitor) and U0126 (MEK inhibitor) were obtained from Calbiochem (San Diego, CA). Methods for constructing Chinese hamster ovary (CHO) cells expressing full-length human EGFR and both EGFR and ErbB4 receptors are described elsewhere [21], [44].
###end p 47
###begin title 48
Cell Culture
###end title 48
###begin p 49
###xml 150 156 <span type="species:ncbi:9913">bovine</span>
###xml 157 161 <span type="species:ncbi:9913">calf</span>
CHO cells expressing EGFR or EGFR and ErbB4 receptors were routinely maintained in DMEM/F12 (Gibco BRL, Githersburg, MD) medium supplemented with 10% bovine calf serum and antibiotics. For detection of the effect of growth hormones, the cells were starved in serum-free DMEM/F12 for 16-24 hours prior to the experiment. To test the effect of kinase and phosphatase inhibitors, the cells were pretreated with the inhibitors 10 min prior to the addition of EGF. The concentration of EGF for cell treatments is 10 nM unless otherwise indicated.
###end p 49
###begin title 50
Western Blot Analysis
###end title 50
###begin p 51
###xml 534 538 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Hatakeyama1">[21]</xref>
###xml 777 785 777 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s002">Table S1</xref>
The protein-protein interactions and protein phosphorylation levels were measured by Western blot analysis. For protein-protein interaction or receptor phosphorylation analysis, proteins were immunoprecipitated with corresponding antibodies and immunoblotted with antibodies for their interacting proteins or anti-phosphotyrosine antibody. We examined ERK phosphorylation as a downstream marker of the MAPK cascade. We used Raf-RDB and a Rap1 pull-down assay as activation markers for Ras and Rap1, respectively, as described earlier [21]. The band intensities of proteins were quantified using a densitometer (Fuji Film Corp, Tokyo, Japan) and normalized by dividing the signal intensity at each time point by the control at 0 min, and then subtracting 1.0 from these values (Table S1), thus generating normalized data with no units. For the B-Raf kinase assay, E1/4 cells were treated with 10 nM EGF for 1, 2, 5, 10 and 30 min. Cell lysate was immunoprecipitated (IP) with an anti-B-Raf antibody and incubated with a MEK substrate. MEK phosphorylation was examined with an antibody against phospho-(Ser218/222) MEK1 and phospho-(Ser222/226) MEK2 followed by densitometric quantification.
###end p 51
###begin title 52
Construction of the Raf-MEK-ERK cascade model
###end title 52
###begin p 53
###xml 171 179 171 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g002">Figure 2</xref>
###xml 218 221 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">259</sup>
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Dhillon1">[45]</xref>
###xml 237 241 237 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Kubicek1">[46]</xref>
###xml 325 329 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-York1">[37]</xref>
###xml 331 335 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Zwartkruis1">[41]</xref>
###xml 398 402 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Kolch1">[31]</xref>
###xml 455 459 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Huang1">[25]</xref>
###xml 461 465 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Markevich1">[28]</xref>
###xml 671 675 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Zhou1">[47]</xref>
###xml 677 681 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Keyse1">[48]</xref>
The model was constructed on the basis of observations made in earlier studies. Raf-1 activity is promoted by the association with an activated form of Ras-GTP (step 1 in Figure 2) and reduced by phosphorylation on Ser259 (step 2) [45], [46]. B-Raf can be activated through PLCgamma and subsequent small GTPase Rap1 (step 3) [37], [41]. MEK is directly activated by Raf-1 and B-Raf (steps 5 and 6) [31], and then doubly phosphorylates ERK (steps 8 and 9) [25], [28]. The MAPK cascade can be negatively modulated by protein phosphatase 2A (PP2A) through dephosphorylation of MEK (step 7) and by MAPK phosphatase 3 (MKP3) through dephosphorylation of ERK (steps 10 and 11) [47], [48]. Steps 12-19 were prepared as possible connections regarding feedback/cross-talk regulations.
###end p 53
###begin title 54
Procedure of model selection based on parameter estimation
###end title 54
###begin p 55
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Kimura1">[49]</xref>
###xml 269 272 269 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ERR</italic>
###xml 427 428 427 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 450 451 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 470 478 470 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s002">Table S1</xref>
###xml 754 762 754 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001782-g002">Figure 2</xref>
###xml 856 857 856 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 857 858 857 858 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sub>
###xml 861 862 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 862 863 862 863 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sub>
###xml 931 939 931 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s002">Table S1</xref>
For each of the 29 candidate structures, we initially performed three rounds of parameter estimation whilst changing the starting points for the parameter search. As an estimator, we used the genetic algorithm GLSDC [49]. The error equation that is optimized by GLSDC, ERR, was defined by the total sum of squares relating the gap between the experimental data and simulated values at each time point as follows:where the sets P = {p-ERK, p-MEK} and D are obtained from Table S1 (nos. 1 and 2). Additionally, we imposed a quantitative effect relating to U0126 for each candidate as a constraint on the estimator. U0126 is an irreversible inhibitor of MEK and functionally lowers the maximum velocity of this enzyme. We set the velocity (steps 8 and 9 in Figure 2) to 0 to represent complete inhibition. Then the peak level of simulated MEK activation with V8 = V9 = 0 should be lower than that of the experimental data with U0126 (Table S1, no. 3). The following constraints were therefore imposed during estimation for E1 and E1/4 cells, respectively:With this setting, the total concentration of each protein equals unity. We assumed that all proteins are inactive prior to EGF simulation. We then evaluated each of the estimated parameters using the quantitative criteria (1)-(3) as outlined below, and selected one that satisfied most of the criteria of the three trials. If the number of satisfied criteria was identical, one that yielded the smallest estimation error was selected. The criteria for model selection were defined as follows:
###end p 55
###begin p 56
Estimation error
###end p 56
###begin p 57
###xml 23 24 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 33 34 32 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 52 60 51 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s002">Table S1</xref>
For each data point in DwhereSet D is obtained from Table S1 (nos. 1 and 2). The 25% of the maximum experimental value was used as a threshold since the model describes topological regulation rather than detailed molecular mechanism, and might not result in perfect fitting.
###end p 57
###begin p 58
Effect of U0126 (the inequalities (2) and (3))
###end p 58
###begin p 59
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUR</italic>
###xml 173 174 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sub>
###xml 172 174 172 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t<sub>s</sub></italic>
###xml 268 269 268 269 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sub>
###xml 267 269 267 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t<sub>e</sub></italic>
###xml 304 305 304 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sub>
###xml 303 305 303 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t<sub>s</sub></italic>
###xml 381 384 381 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUR</italic>
###xml 524 532 524 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s002">Table S1</xref>
Sustained B-Raf activation in E1/4 cellswhere DUR represents the duration time calculated from the time-course data generated using the model for E1/4 cells, and defined byts represents that time point at which B-Raf activity exceeds 70% of the maximum activity, and te represents that time point after ts at which B-Raf activity becomes lower than 70% of the maximum activity. If DUR values are present due to oscillatory behavior, the maximum one is used. From the experimental results, the threshold was set to 1000 sec (Table S1, no. 6).
###end p 59
###begin title 60
Parameter estimation of upstream model
###end title 60
###begin p 61
###xml 56 57 56 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 98 99 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 112 120 112 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s002">Table S1</xref>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Kholodenko1">[26]</xref>
###xml 274 282 274 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s010">Table S9</xref>
###xml 898 919 898 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001782-t001">Table 1, nos. 4, 8&#8211;10</xref>
The error equation in GLSDC was defined by Eq. (1) with P = {p-EGFR, p-Shc, Ras-GTP, p-ErbB4} and D as shown in Table S1 (nos. 4, 8-10). The search range for an estimated parameter was limited within a neighbor of the corresponding value provided in the earlier study [26] (Table S9). Additionally, we assumed that the parameter values associated with step nos. 1-12 were identical for E1 and E1/4 cells. Since ShcP-GS bound to EGFR regulates Ras activation in both step nos. 12 and 22, the parameter value of step no. 22 was considered to be identical to that of step no. 12 for simplicity, although the kinetic parameter might not be necessarily the same given the different dimer partners (EGFR or ErbB4). Use of these constraints facilitated selection during the course of the fitting. Under these conditions, we performed ten rounds of parameter estimation to reproduce the experimental data (Table 1, nos. 4, 8-10) since the upstream model seemed to be more complex than the topological Raf-MEK-ERK model. Finally, the parameter that yielded the smallest estimation error was selected.
###end p 61
###begin title 62
Model Development
###end title 62
###begin p 63
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Heinrich1">[24]</xref>
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Kholodenko1">[26]</xref>
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Hatakeyama2">[29]</xref>
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Schoeberl1">[42]</xref>
###xml 383 404 383 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 760 764 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001782-Kimura1">[49]</xref>
To describe the biochemical reactions and connectivity of signaling molecules in this study, we adopted a deterministic ordinary differential equation (ODE) model. This methodology has been employed in many studies using the law of mass action and the Michaelis-Menten equation [24], [26], [29], [42]. The model was created to reproduce the normalized experimental data mentioned in Materials and Methods and was implemented with MATLAB 5.1 (The Mathworks, Inc.) on an AMD Opteron 2.2GHz workstation running SuSE Linux Enterprise Server 9 (Novell). The MATLAB function "ode15s" was applied to solve the ODE ( access/helpdesk/help/techdoc/ref/ode15s.html). All code is available upon request. As a model parameter estimator, we used the genetic algorithm GLSDC [49]. The program was run on the RIKEN Super Combined Cluster (RSCC) system.
###end p 63
###begin title 64
Supporting Information
###end title 64
###begin p 65
(0.03 MB DOC)
###end p 65
###begin p 66
Click here for additional data file.
###end p 66
###begin p 67
(0.03 MB XLS)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
(0.02 MB XLS)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
(0.02 MB XLS)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
(0.03 MB XLS)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
(0.02 MB XLS)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
(0.02 MB XLS)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
(0.02 MB XLS)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
(0.02 MB XLS)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
(0.03 MB XLS)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
The effect of MEK inhibitor U0126 on ERK phosphorylation in E1 and E1/4 cells. Serum-starved E1 and E1/4 cells were incubated with 10 nM EGF for the indicated time period with or without pretreatment of 200 nM U0126. ERK phosphorylation was analyzed by Western blot with the corresponding anti-phospho-specific ERK antibodies (upper panel), and then reblotted with an anti-ERK antibody (lower panel). (A) Western blot for E1 cells. (B) Western blot for E1/4 cells. Data show a representative figure of three independent experiments.
###end p 85
###begin p 86
(1.67 MB TIF)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 88 91 88 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">act</sub>
###xml 112 117 112 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">deact</sub>
###xml 134 137 134 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">act</sub>
###xml 155 160 155 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">deact</sub>
###xml 291 294 291 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">act</sub>
###xml 461 464 461 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">act</sub>
###xml 467 472 467 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">deact</sub>
###xml 552 553 552 553 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 556 557 556 557 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 580 581 580 581 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 584 585 584 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Transfer function model of the signaling pathways. (A) The substrate S is activated by Eact and deactivated by Edeact. The activator Eact and deactivator Edeact can be indirectly activated by ligand. (B) Figure shows a practical example of (A). When the substrate S is Raf-1, the activator Eact corresponds to Ras-GTP that is indirectly activated by EGF through some signaling molecules such as Shc, Grb2, and SOS. (C) The intermediate reactions between L and Eact (Edeact) are approximated by the first-order transfer function with the time constant T1 (T2) and the system gain G1 (G2).
###end p 88
###begin p 89
(0.72 MB TIF)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
###xml 287 288 287 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 291 292 291 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 295 296 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 302 303 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 479 487 479 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s003">Table S2</xref>
###xml 542 550 542 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001782.s004">Table S3</xref>
Model of input signal generator for Ras- and Rap1-GTPs. The input signal generator reproduces the time-course data of Ras- and Rap1-GTPs with 10 nM EGF. The model is constructed with eight transfer functions (steps 20-27). The outputs of the transfer functions regulate the activity of S1, S2, S3 and S4, which are activators or deactivators for Ras and Rap1 (steps 28-35). Ras and Rap1 activity is then regulated by those components (steps 36-39). The symbols are summarized in Table S2. Numbers shown correspond to the kinetic equations in Table S3.
###end p 91
###begin p 92
(0.61 MB TIF)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
###xml 646 647 646 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 653 654 653 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
Fitting results of the 29 structures. This Figure contains 29x4 figures where row corresponds to a structure number, and column activated proteins. Blue and red lines (markers) indicate simulation (experimental) results of E1 and E1/4 cells, respectively. If a structure satisfied criteria (1)-(3) of the main text, the word "pass" was put on the upper side of each figure, otherwise "fail" was put on there. Error bar indicates the upper and lower bounds calculated from criterion (1) of the main text. A value on the upper side of a figure in column 4 shows the duration time. Green and magenta colors mean "pass" and "fail", respectively. The x- and y-axes represent time (min) and activation (% of total protein), respectively.
###end p 94
###begin p 95
(0.34 MB PDF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
We thank Dr. Shuhei Kimura (Tottori University, Japan) for providing advice on parameter estimation. All parallel computation was performed by using RIKEN Super Combined Cluster (RSCC).
###end p 97
###begin title 98
References
###end title 98
###begin article-title 99
The ErbB signaling network: receptor heterodimerization in development and cancer.
###end article-title 99
###begin article-title 100
Untangling the ErbB signalling network.
###end article-title 100
###begin article-title 101
Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival.
###end article-title 101
###begin article-title 102
Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members.
###end article-title 102
###begin article-title 103
ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.
###end article-title 103
###begin article-title 104
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation.
###end article-title 104
###begin article-title 105
Phosphotyrosine interactome of the ErbB-receptor kinase family.
###end article-title 105
###begin article-title 106
The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions.
###end article-title 106
###begin article-title 107
All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired.
###end article-title 107
###begin article-title 108
###xml 25 30 <span type="species:ncbi:9606">human</span>
The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells.
###end article-title 108
###begin article-title 109
Quantitative transcriptional control of ErbB receptor signaling undergoes graded to biphasic response for cell differentiation.
###end article-title 109
###begin article-title 110
Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells.
###end article-title 110
###begin article-title 111
The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions.
###end article-title 111
###begin article-title 112
Regulation of Raf-Akt Cross-talk.
###end article-title 112
###begin article-title 113
Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells.
###end article-title 113
###begin article-title 114
SOS phosphorylation and disassociation of the Grb2-SOS complex by the ERK and JNK signaling pathways.
###end article-title 114
###begin article-title 115
Epidermal growth factor receptor targeting prevents uncoupling of the Grb2-SOS complex.
###end article-title 115
###begin article-title 116
Identification of novel in vivo Raf-1 phosphorylation sites mediating positive feedback Raf-1 regulation by extracellular signal-regulated kinase.
###end article-title 116
###begin article-title 117
Identification of novel ERK-mediated feedback phosphorylation sites at the C-terminus of B-Raf.
###end article-title 117
###begin article-title 118
Regulation of Raf-1 by direct feedback phosphorylation.
###end article-title 118
###begin article-title 119
Transformation potency of ErbB heterodimer signaling is determined by B-Raf kinase.
###end article-title 119
###begin article-title 120
Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.
###end article-title 120
###begin article-title 121
Regulation and role of Raf-1/B-Raf heterodimerization.
###end article-title 121
###begin article-title 122
Mathematical models of protein kinase signal transduction.
###end article-title 122
###begin article-title 123
Ultrasensitivity in the mitogen-activated protein kinase cascade.
###end article-title 123
###begin article-title 124
Quantification of short term signaling by the epidermal growth factor receptor.
###end article-title 124
###begin article-title 125
Identification of a novel inhibitor of mitogen-activated protein kinase kinase.
###end article-title 125
###begin article-title 126
Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades.
###end article-title 126
###begin article-title 127
A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling.
###end article-title 127
###begin article-title 128
Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells.
###end article-title 128
###begin article-title 129
Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.
###end article-title 129
###begin article-title 130
Regulation of the Ras signalling network.
###end article-title 130
###begin article-title 131
###xml 110 115 <span type="species:ncbi:9606">human</span>
Expression of the ErbB4 receptor causes reversal regulation of PP2A in the Shc signal transduction pathway in human cancer cells.
###end article-title 131
###begin article-title 132
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
###end article-title 132
###begin article-title 133
Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases.
###end article-title 133
###begin article-title 134
Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate.
###end article-title 134
###begin article-title 135
Rap1 mediates sustained MAP kinase activation induced by nerve growth factor.
###end article-title 135
###begin article-title 136
###xml 56 63 <span type="species:ncbi:8355">Xenopus</span>
Inhibition of ras-induced germinal vesicle breakdown in Xenopus oocytes by rap-1B.
###end article-title 136
###begin article-title 137
###xml 79 82 <span type="species:ncbi:10116">Rat</span>
RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts.
###end article-title 137
###begin article-title 138
###xml 30 33 <span type="species:ncbi:9860">Elk</span>
cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway.
###end article-title 138
###begin article-title 139
Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling.
###end article-title 139
###begin article-title 140
Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors.
###end article-title 140
###begin article-title 141
Modeling the effects of HER/ErbB1-3 coexpression on receptor dimerization and biological response.
###end article-title 141
###begin article-title 142
Chimeric receptor analyses of the interactions of the ectodomains of ErbB-1 with epidermal growth factor and of those of ErbB-4 with neuregulin.
###end article-title 142
###begin article-title 143
Untying the regulation of the Raf-1 kinase.
###end article-title 143
###begin article-title 144
Dephosphorylation of Ser-259 regulates Raf-1 membrane association.
###end article-title 144
###begin article-title 145
The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases.
###end article-title 145
###begin article-title 146
Protein phosphatases and the regulation of mitogen-activated protein kinase signalling.
###end article-title 146
###begin article-title 147
High Dimensional Function Optimization using a new Genetic Local Search suitable for Parallel Computers.
###end article-title 147
###begin p 148
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 148
###begin p 149
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Ordinary research budget
###end p 149

